Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the update of its ...
This press release contains forward-looking statements about Mauna Kea Technologies and its business. All statements other than statements of historical fact included in this press release, including, ...
The first component aims to significantly reduce the Company's debt from €40 million today to approximately €10 million after the adoption of the safeguard plan. The second component of the safeguard ...
Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. A 2022 state law creating the authority gave the entity ...
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, announced it has secured firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results